论文期刊

取消

高级检索

检索历史清除

首页> Human gene therapy> Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.

Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.

导出 OA

翻译打印收藏纠错

第一作者： Wenpeng,Li

第一单位： 1 Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas.

作者： Wenpeng,Li ^[1] ; Linjie,Guo ^[2] ; Purva,Rathi ^[3] ; Ekaterina,Marinova ^[1] ; Xiuhua,Gao ^[2] ; Meng-Feng,Wu ^[3] ; Hao,Liu ^[4] ; Gianpietro,Dotti ^[1] ; Stephen,Gottschalk ^[2] ; Leonid S,Metelitsa ^[3] ; Andras,Heczey ^[1]

作者单位： 1 Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas. ^[1] 2 Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, Texas. ^[2] 3 Department of Pediatrics, Houston, Texas. ^[3] 4 Biostatistics Shared Resource, Dan L Duncan Comprehensive Cancer Center, Houston, Texas. ^[4] 5 Department of Microbiology and Immunology, University of North Carolina , Chapel Hill, North Carolina. ^[5] 6 Department of Pathology and Immunology; Baylor College of Medicine, Houston, Texas. ^[6]

关键词 T-cell therapy chimeric antigen receptor glypican-3 hepatoblastoma hepatocellular carcinoma immunotherapy rhabdoid tumor

主题词动物(Animals);抗原, CD19(Antigens, CD19);细胞极性(Cell Polarity);磷脂酰肌醇蛋白聚糖类(Glypicans);人类(Humans);免疫疗法(Immunotherapy);淋巴瘤, B细胞(Lymphoma, B-Cell);小鼠(Mice);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);T淋巴细胞(T-Lymphocytes);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.1089/hum.2016.025

PMID 27530312

发布时间 2022-04-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

Human gene therapy

Human gene therapy

2017年28卷5期

437-448页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷